-
PDF
- Split View
-
Views
-
Cite
Cite
A. R. Schmidt, P. Buehler, L. Seglias, T. Stark, B. Brotschi, T. Renner, C. Sabandal, R. Klaghofer, M. Weiss, A. Schmitz, Gastric pH and residual volume after 1 and 2 h fasting time for clear fluids in children, BJA: British Journal of Anaesthesia, Volume 114, Issue 3, March 2015, Pages 477–482, https://doi.org/10.1093/bja/aeu399
- Share Icon Share
Abstract
Current guidelines suggest a fasting time of 2 h for clear fluids, which is often exceeded in clinical practice, leading to discomfort, dehydration and stressful anaesthesia induction to patients, especially in the paediatric population. Shorter fluid fasting might be a strategy to improve patient comfort but has not been investigated yet. This prospective clinical trial compares gastric pH and residual volume after 1 vs 2 h of preoperative clear fluid fasting.
Children (1–16 yr, ASA I or II) undergoing elective procedures in general anaesthesia requiring tracheal intubation were randomized into group A with 60 min or B with 120 min preoperative clear fluid fasting. To determine gastric pH and residual volume, the gastric content was sampled in supine, left and right lateral patient position using an oro-gastric tube after intubation. Data are median (interquartile range) for group A or B (P<0.05).
In total, 131 children aged 1.01–16.23 yr were included; gastric pH was determined in 120 cases. Patient characteristic data were similar between the two groups, except for gender (46/33 males in group A/B; P=0.02). Despite significantly shorter fasting times for clear fluids in group A compared with group B (76/136 min; P<0.001), no significant difference was observed regarding gastric pH [1.43 (1.30–1.56)/1.44 (1.29–1.68), P=0.66] or residual volume [0.43 (0.21–0.84)/0.46 (0.19–0.78) ml kg−1, P=0.47].
One hour clear fluid fasting does not alter gastric pH or residual volume significantly compared with 2 h fasting.
The study was approved by the local ethics committee (KEK-ZH-Nr. 2011-0034) and registered with ClinicalTrials.gov (NCT01516775).
The main objective of this study was to compare gastric pH and residual gastric volume after 1 vs 2 h pre-anaesthetic clear fluid fasting in children.
Similar gastric pH or residual gastric volume indexed to body weight were found after 1 vs 2 h of clear fluid fasting.
One hour fluid fast did not reveal relevant advantages concerning hunger and thirst, induction quality, recovery, and parental satisfaction compared with 2 h of clear fluid fasting.
The data presented do not provide evidence against fluid fasting shorter than currently recommended.
Pre-anaesthetic fasting is the main strategy used to avoid perioperative pulmonary aspiration in elective procedures requiring general anaesthesia. Current international guidelines provide fasting rules that consider safety and also patient hydration, homeostasis and comfort (i.e. 2 h for clear fluids and 6 h for light meals and non-clear fluids).1–3 Nevertheless, children still suffer from prolonged preoperative fasting for various reasons like communication problems, organizational delay (re-scheduling, incalculable duration of preceding procedures), or not being woken up for a drink if their procedure is scheduled early in the morning.4–6 Data from volunteer studies indicate that the gastric emptying half-life after clear fluid intake is short, with gastric volumes returning to baseline within 1 h after drinking.7 However, clear fluid fasting shorter than 2 h has not yet been investigated in a clinical setting.
The main objective of this study was to compare gastric pH and residual gastric volume after 1 vs 2 h pre-anaesthetic clear fluid fasting in children undergoing elective procedures with general anaesthesia.
Methods
The study was approved by the local ethics committee (KEK-ZH-Nr. 2011-0034) and registered with ClinicalTrials.gov (NCT01516775). Written parental consent was given after oral and written information during the pre-anaesthetic visit.
Inclusion criteria in this prospective randomized clinical trial were: age 1–16 yr, ASA physical state I or II without gastrointestinal disorders (including oesophageal reflux, hiatus hernia, or gastritis), and elective procedures requiring general anaesthesia with tracheal intubation. To ensure correct fluid fasting times, children were scheduled first or second with a predetermined anaesthesia starting time. Exclusion criteria were any violation of the prescribed fasting times with respect to the amount of fluid (drinking 50% more than the prescribed liquid volume) or time, and refusing to drink any prescribed clear fluid according to the protocol.
Primary outcome measures were the gastric pH and residual gastric volume (GFVw) after 1 h of clear fluid fasting compared with that after 2 h. Secondary outcome parameters were self-reported hunger and thirst, patient behaviour during induction of anaesthesia and in the recovery room, and also parents’ satisfaction with fasting period, anaesthesia induction, and awakening.
Patients were randomized into groups A and B with 60 and 120 min, respectively, of fasting time after clear fluids. Randomization was stratified in two age groups (age <6 yr and 6 yr or older) using random lists (www.random.org) for allocation to groups A and B within blocks of eight numbers. The amount of recommended clear fluid intake before anaesthesia was 5 µl kg−1 body weight, limited to a maximum of 150 ml. The anaesthesia team, which also performed sampling of gastric fluid, and also recovery room nurses were blinded to the duration of clear fluid fasting. Neither solid food nor non-clear fluid was allowed for at least 6 h before anaesthesia.
The amount and time of clear fluid intake were noted, and children were pre-medicated with midazolam per os or rectally. Before induction of anaesthesia, patients were asked to rate their feeling of hunger or thirst, if not too sedated because of the midazolam premedication. Anaesthesia was induced by the inhalation route using sevoflurane in nitrous oxide and oxygen followed by i.v. cannula placement and the application of atracurium (0.5 mg kg−1) or by the i.v. route using alfentanil (10–20 μg kg−1), propofol (3–4 mg kg−1), and atracurium (0.5 mg kg−1). A venous blood gas sample was taken immediately after i.v. access was established, and analysed for pH, blood glucose, base excess, and lactate (ABL 800 Flex blood gas analyser, Radiometer Medical ApS, Brønshøj, Denmark). Gastric fluid was aspirated with a 10 ml syringe via the oro-gastric tube (size 10/12/14 Charrière for children weighing <15/15–25/> 25 kg, respectively) in supine, left-lateral, and right-lateral positions. Placement of the oro-gastric tube was confirmed by auscultation of the stomach and optimized in each position. The total aspirated volume was recorded and the sample was analysed for gastric fluid pH (pH-Meter Orion 230A, Thermo Fisher Scientific, Chelmsford, MA, USA), with a minimum sample volume of 1 ml required.
In the recovery room the quality of awakening including agitation and pain, incidence of postoperative nausea and vomiting, and application of antiemetic therapy were recorded. The parents were asked to answer structured questions regarding their satisfaction with the fasting period, induction, and awakening of their child.
Assuming that a shorter fasting time for clear fluids before anaesthesia might elevate gastric pH, power calculation suggested a sample size of at least 63 participants in each group to detect a difference in gastric pH of at least 0.5, with a two-sided significance of α=0.05 and a power of 80%. Data were recorded using SecuTrial® (InterActive Systems Berlin, Germany, technical support by Clinical Trial Centre, University Hospital, Zurich), a software that supports ‘good clinical practice’ requirements, and monitored by a person not otherwise involved in this trial. Data were analysed using Microsoft Excel 2003 (Microsoft Corporation, Redmond, WA, USA) and SPSS 17.0 (SPSS, Inc., Chicago, IL, USA). Spearman-Rho was used to detect correlation between non-parametric data. Where not declared otherwise, median and interquartile range (IQR) were used to describe non-parametric and ordinal data. The differences in gastric pH and residual gastric volume between the two groups are shown as mean difference and 95% confidence interval (95% CI). The level of significance was tested with Whitney–Mann U or χ2 test for categorical data, with P<0.05 considered to be statistically significant.
Results
In total 149 children were enrolled. Of these, 18 patients had to be excluded from analysis for the following reasons: prolonged fasting for clear fluid compared with the prescribed drinking time, including refusal to drink before operation (13 children), violation of minimal fasting time for food or non-clear fluid (3 children), placement of oro-gastric tube not possible (1 child), and amount of clear fluid allowed exceeded by >50% (2 children).
The characteristics of the remaining 131 patients did not significantly differ between groups A and B except for gender and—as intended by the protocol—the clear fluid fasting time (Table 1). Anaesthesia technique including mode of induction, midazolam premedication, and application of opioids or prophylactic antiemetics was also similar in both groups.
Patient characteristic data, characteristics of pre-anaesthetic oral intake, and procedures performed. Group A=60 and group B=120 min of clear fluid fasting. Data are median (IQR) or count (%). *Significant with P<0.05
. | Group A (n=65) . | Group B (n=66) . | P-value . |
---|---|---|---|
Age (yr) | 7.34 (4.51–10.02) | 9.04 (4.85–12.77) | 0.31 |
Gender (male) | 46 (71%) | 33 (50%) | 0.02* |
Weight (kg) | 24.00 (16.70–34.50) | 28.80 (17.58–41.05) | 0.38 |
ASA class I/II | 42/23 | 46/20 | 0.54 |
Last fluid—intubation (min) | 76 (73–79) | 136 (133–140) | <0.001* |
Absolute volume of fluid ingested (ml) | 110 (75–150) | 130 (70–150) | 0.43 |
Volume of fluid ingested (ml kg−1) | 4.83 (3.21–5.00) | 4.41 (2.65–5.00) | 0.55 |
Oral premedication with midazolam | 48 (74%) | 52 (79%) | 0.51 |
Midazolam syrup/tablet | 38/10 | 36/16 | 0.26 |
Last meal/none clear fluid—intubation (min) | 772 (717–835) | 783 (721–837) | 0.39 |
General surgery | 4 (6%) | 4 (6%) | 0.98 |
Plastic surgery | 8 (12%) | 7 (11%) | 0.76 |
Orthodontic surgery | 6 (10%) | 7 (11%) | 0.79 |
Urological surgery | 9 (14%) | 12 (18%) | 0.49 |
Orthopaedic surgery | 17 (26%) | 18 (27%) | 0.88 |
Otorhinolaryngeal surgery | 8 (12%) | 6 (9%) | 0.55 |
Diagnostic or interventional heart catheter | 8 (12%) | 9 (14%) | 0.82 |
Other surgical procedures | 5 (8%) | 3 (4%) | 0.45 |
. | Group A (n=65) . | Group B (n=66) . | P-value . |
---|---|---|---|
Age (yr) | 7.34 (4.51–10.02) | 9.04 (4.85–12.77) | 0.31 |
Gender (male) | 46 (71%) | 33 (50%) | 0.02* |
Weight (kg) | 24.00 (16.70–34.50) | 28.80 (17.58–41.05) | 0.38 |
ASA class I/II | 42/23 | 46/20 | 0.54 |
Last fluid—intubation (min) | 76 (73–79) | 136 (133–140) | <0.001* |
Absolute volume of fluid ingested (ml) | 110 (75–150) | 130 (70–150) | 0.43 |
Volume of fluid ingested (ml kg−1) | 4.83 (3.21–5.00) | 4.41 (2.65–5.00) | 0.55 |
Oral premedication with midazolam | 48 (74%) | 52 (79%) | 0.51 |
Midazolam syrup/tablet | 38/10 | 36/16 | 0.26 |
Last meal/none clear fluid—intubation (min) | 772 (717–835) | 783 (721–837) | 0.39 |
General surgery | 4 (6%) | 4 (6%) | 0.98 |
Plastic surgery | 8 (12%) | 7 (11%) | 0.76 |
Orthodontic surgery | 6 (10%) | 7 (11%) | 0.79 |
Urological surgery | 9 (14%) | 12 (18%) | 0.49 |
Orthopaedic surgery | 17 (26%) | 18 (27%) | 0.88 |
Otorhinolaryngeal surgery | 8 (12%) | 6 (9%) | 0.55 |
Diagnostic or interventional heart catheter | 8 (12%) | 9 (14%) | 0.82 |
Other surgical procedures | 5 (8%) | 3 (4%) | 0.45 |
Patient characteristic data, characteristics of pre-anaesthetic oral intake, and procedures performed. Group A=60 and group B=120 min of clear fluid fasting. Data are median (IQR) or count (%). *Significant with P<0.05
. | Group A (n=65) . | Group B (n=66) . | P-value . |
---|---|---|---|
Age (yr) | 7.34 (4.51–10.02) | 9.04 (4.85–12.77) | 0.31 |
Gender (male) | 46 (71%) | 33 (50%) | 0.02* |
Weight (kg) | 24.00 (16.70–34.50) | 28.80 (17.58–41.05) | 0.38 |
ASA class I/II | 42/23 | 46/20 | 0.54 |
Last fluid—intubation (min) | 76 (73–79) | 136 (133–140) | <0.001* |
Absolute volume of fluid ingested (ml) | 110 (75–150) | 130 (70–150) | 0.43 |
Volume of fluid ingested (ml kg−1) | 4.83 (3.21–5.00) | 4.41 (2.65–5.00) | 0.55 |
Oral premedication with midazolam | 48 (74%) | 52 (79%) | 0.51 |
Midazolam syrup/tablet | 38/10 | 36/16 | 0.26 |
Last meal/none clear fluid—intubation (min) | 772 (717–835) | 783 (721–837) | 0.39 |
General surgery | 4 (6%) | 4 (6%) | 0.98 |
Plastic surgery | 8 (12%) | 7 (11%) | 0.76 |
Orthodontic surgery | 6 (10%) | 7 (11%) | 0.79 |
Urological surgery | 9 (14%) | 12 (18%) | 0.49 |
Orthopaedic surgery | 17 (26%) | 18 (27%) | 0.88 |
Otorhinolaryngeal surgery | 8 (12%) | 6 (9%) | 0.55 |
Diagnostic or interventional heart catheter | 8 (12%) | 9 (14%) | 0.82 |
Other surgical procedures | 5 (8%) | 3 (4%) | 0.45 |
. | Group A (n=65) . | Group B (n=66) . | P-value . |
---|---|---|---|
Age (yr) | 7.34 (4.51–10.02) | 9.04 (4.85–12.77) | 0.31 |
Gender (male) | 46 (71%) | 33 (50%) | 0.02* |
Weight (kg) | 24.00 (16.70–34.50) | 28.80 (17.58–41.05) | 0.38 |
ASA class I/II | 42/23 | 46/20 | 0.54 |
Last fluid—intubation (min) | 76 (73–79) | 136 (133–140) | <0.001* |
Absolute volume of fluid ingested (ml) | 110 (75–150) | 130 (70–150) | 0.43 |
Volume of fluid ingested (ml kg−1) | 4.83 (3.21–5.00) | 4.41 (2.65–5.00) | 0.55 |
Oral premedication with midazolam | 48 (74%) | 52 (79%) | 0.51 |
Midazolam syrup/tablet | 38/10 | 36/16 | 0.26 |
Last meal/none clear fluid—intubation (min) | 772 (717–835) | 783 (721–837) | 0.39 |
General surgery | 4 (6%) | 4 (6%) | 0.98 |
Plastic surgery | 8 (12%) | 7 (11%) | 0.76 |
Orthodontic surgery | 6 (10%) | 7 (11%) | 0.79 |
Urological surgery | 9 (14%) | 12 (18%) | 0.49 |
Orthopaedic surgery | 17 (26%) | 18 (27%) | 0.88 |
Otorhinolaryngeal surgery | 8 (12%) | 6 (9%) | 0.55 |
Diagnostic or interventional heart catheter | 8 (12%) | 9 (14%) | 0.82 |
Other surgical procedures | 5 (8%) | 3 (4%) | 0.45 |
Absolute gastric sample volumes ranged from zero to a maximum of 91 vs 85 ml [13 (5–26)/14 (5–21) ml, P=0.69] in groups A and B, respectively, with gastric pH being analysed in 120 patients (group A=61, group B=59). In 11 patients gastric pH could not be measured because the sample volume was <1 ml. Gastric pH and residual gastric fluid volumes indexed to body weight are presented in Table 2. There was no significant difference between 1 and 2 h of pre-anaesthetic clear fluid fasting for either gastric pH (P=0.66; mean difference 0.10, 95% CI −0.30–0.07) or GFVw (P=0.47; mean difference 0.14, 95% CI −0.04–0.32). The distribution of gastric pH and GFVw values in relation to the recorded intervals of fluid fasting is depicted in Figures 1 and 2. The residual gastric fluid volume varied considerably in both groups, with GFVw >1 ml kg−1 in 13 (20%) and 5 (7.6%) children in groups A and B, respectively (P=0.039).
Gastric pH and gastric residual volume (GFVw; ml kg−1) between last clear fluid intake and intubation (fluid sampling). Group A=60 and group B=120 min of clear fluid fasting. Significant if P<0.05. IQR, interquartile range; sd, standard deviation; CI, confidence interval. Gastric pH not available in patients with a sample volume of <1 ml
Gastric pH | Group A (n=59) | Group B (n=61) | P-value |
Median | 1.43 | 1.44 | 0.66 |
IQR | 1.30–1.56 | 1.29–1.68 | |
Range | 0.51–2.20 | 0.35–5.93 | |
Mean (sd) | 1.44 (0.26) | 1.55 (0.68) | |
CI | 1.37–1.50 | 1.37–1.72 | |
GFVw (ml kg−1) | Group A (n=65) | Group B (n=66) | P-value |
Median | 0.43 | 0.46 | 0.47 |
IQR | 0.21–0.84 | 0.19–0.78 | |
Range | 0.00–3.39 | 0.00–1.89 | |
Mean (sd) | 0.64 (0.63) | 0.50 (0.40) | |
CI | 0.48–0.79 | 0.40–0.60 |
Gastric pH | Group A (n=59) | Group B (n=61) | P-value |
Median | 1.43 | 1.44 | 0.66 |
IQR | 1.30–1.56 | 1.29–1.68 | |
Range | 0.51–2.20 | 0.35–5.93 | |
Mean (sd) | 1.44 (0.26) | 1.55 (0.68) | |
CI | 1.37–1.50 | 1.37–1.72 | |
GFVw (ml kg−1) | Group A (n=65) | Group B (n=66) | P-value |
Median | 0.43 | 0.46 | 0.47 |
IQR | 0.21–0.84 | 0.19–0.78 | |
Range | 0.00–3.39 | 0.00–1.89 | |
Mean (sd) | 0.64 (0.63) | 0.50 (0.40) | |
CI | 0.48–0.79 | 0.40–0.60 |
Gastric pH and gastric residual volume (GFVw; ml kg−1) between last clear fluid intake and intubation (fluid sampling). Group A=60 and group B=120 min of clear fluid fasting. Significant if P<0.05. IQR, interquartile range; sd, standard deviation; CI, confidence interval. Gastric pH not available in patients with a sample volume of <1 ml
Gastric pH | Group A (n=59) | Group B (n=61) | P-value |
Median | 1.43 | 1.44 | 0.66 |
IQR | 1.30–1.56 | 1.29–1.68 | |
Range | 0.51–2.20 | 0.35–5.93 | |
Mean (sd) | 1.44 (0.26) | 1.55 (0.68) | |
CI | 1.37–1.50 | 1.37–1.72 | |
GFVw (ml kg−1) | Group A (n=65) | Group B (n=66) | P-value |
Median | 0.43 | 0.46 | 0.47 |
IQR | 0.21–0.84 | 0.19–0.78 | |
Range | 0.00–3.39 | 0.00–1.89 | |
Mean (sd) | 0.64 (0.63) | 0.50 (0.40) | |
CI | 0.48–0.79 | 0.40–0.60 |
Gastric pH | Group A (n=59) | Group B (n=61) | P-value |
Median | 1.43 | 1.44 | 0.66 |
IQR | 1.30–1.56 | 1.29–1.68 | |
Range | 0.51–2.20 | 0.35–5.93 | |
Mean (sd) | 1.44 (0.26) | 1.55 (0.68) | |
CI | 1.37–1.50 | 1.37–1.72 | |
GFVw (ml kg−1) | Group A (n=65) | Group B (n=66) | P-value |
Median | 0.43 | 0.46 | 0.47 |
IQR | 0.21–0.84 | 0.19–0.78 | |
Range | 0.00–3.39 | 0.00–1.89 | |
Mean (sd) | 0.64 (0.63) | 0.50 (0.40) | |
CI | 0.48–0.79 | 0.40–0.60 |

Gastric residual volume (GFVw; ml kg-1) vs time (minutes) between last clear fluid intake and intubation (fluid sampling). Statistical details provided in Table 2..

Gastric pH vs time (minutes) between last clear fluid intake and intubation (fluid sampling). Statistical details provided in Table 2.
Gastric pH showed very weak but statistical significant negative correlations with age and weight (r=−0.25/P=0.007 and r=−0.27/P=0.003). There was also a very weak but statistical significant correlation between gastric pH and amount of last fluid intake (r=0.19, P=0.04) for which fluid fasting (i.e. 60 vs 120 min) seemed to be a moderator (r=0.37/P=0.003 in group A vsr=0.068/P=0.6 for group B). GFVw did not correlate with age, weight, or amount of last clear fluid intake.
Hunger and thirst at the time of anaesthesia start if evaluable, blood gas analysis at the time of induction, quality of induction and recovery, and also incidence of postoperative nausea and vomiting were not significantly different between groups A and B, see Table 3. Parental satisfaction according to a structured interview was similar between the two groups except for ‘satisfied with fasting time for clear fluid intake’, see Table 4.
Self-reported hunger and thirst, induction quality, blood gas analysis, and patient behaviour in the recovery room. †Ratings defined as follows: hunger/thirst: 0=not at all hungry/thirsty; 1=little hunger/thirst; 2=hungry/thirsty; 3=very hungry/thirsty; Induction quality: 1=satisfied and cooperative; 2=anxious but cooperative; 3=reluctant and uncooperative; 4=crying; 5=having a tantrum; Recovery: 1=satisfied and cooperative; 2=experiencing pain but cooperative; 3=agitated; 4=emergence delirium; 5=emergence delirium requiring droperidol. PONV rescue, postoperative nausea and vomiting requiring rescue medication. Group A=60 and group B=120 min of clear fluid fasting. Data are median (IQR) or count (%)
. | Group A . | Group B . | P-value . |
---|---|---|---|
Hunger score (n=37/39) | 1 (0–2) | 1 (0–1) | 0.91 |
Thirst score† (n=37/39) | 1 (0–2) | 1 (0–1) | 0.25 |
Induction quality (n=65/66) | 1 (1–1) | 1 (1–1) | 0.11 |
Venous pH (n=59/61) | 7.35 (7.33–7.38) | 7.35 (7.33–7.38) | 0.41 |
Venous base excess (n=59/61) | −1.5 (−2.53–−0.83) | −1.75 (−2.9–−0.43) | 0.82 |
Venous blood glucose (n=59/61) | 5.2 (4.9–5.78) | 5.3 (4.9–5.78) | 0.82 |
Venous lactate (n=59/61) | 1.2 (0.9–1.58) | 1.0 (0.8–1.4) | 0.08 |
Nausea after operation (n=65/66) | 8 (12.5%) | 9 (13.84%) | 0.82 |
Vomiting after operation (n=65/66) | 3 (4.69%) | 4 (6.06%) | 0.73 |
PONV rescue (n=65/66) | 8 (12.3%) | 9 (13.63%) | 0.82 |
Recovery quality (n=65/66) | 1 (1–2) | 1 (1–2) | 0.74 |
. | Group A . | Group B . | P-value . |
---|---|---|---|
Hunger score (n=37/39) | 1 (0–2) | 1 (0–1) | 0.91 |
Thirst score† (n=37/39) | 1 (0–2) | 1 (0–1) | 0.25 |
Induction quality (n=65/66) | 1 (1–1) | 1 (1–1) | 0.11 |
Venous pH (n=59/61) | 7.35 (7.33–7.38) | 7.35 (7.33–7.38) | 0.41 |
Venous base excess (n=59/61) | −1.5 (−2.53–−0.83) | −1.75 (−2.9–−0.43) | 0.82 |
Venous blood glucose (n=59/61) | 5.2 (4.9–5.78) | 5.3 (4.9–5.78) | 0.82 |
Venous lactate (n=59/61) | 1.2 (0.9–1.58) | 1.0 (0.8–1.4) | 0.08 |
Nausea after operation (n=65/66) | 8 (12.5%) | 9 (13.84%) | 0.82 |
Vomiting after operation (n=65/66) | 3 (4.69%) | 4 (6.06%) | 0.73 |
PONV rescue (n=65/66) | 8 (12.3%) | 9 (13.63%) | 0.82 |
Recovery quality (n=65/66) | 1 (1–2) | 1 (1–2) | 0.74 |
Self-reported hunger and thirst, induction quality, blood gas analysis, and patient behaviour in the recovery room. †Ratings defined as follows: hunger/thirst: 0=not at all hungry/thirsty; 1=little hunger/thirst; 2=hungry/thirsty; 3=very hungry/thirsty; Induction quality: 1=satisfied and cooperative; 2=anxious but cooperative; 3=reluctant and uncooperative; 4=crying; 5=having a tantrum; Recovery: 1=satisfied and cooperative; 2=experiencing pain but cooperative; 3=agitated; 4=emergence delirium; 5=emergence delirium requiring droperidol. PONV rescue, postoperative nausea and vomiting requiring rescue medication. Group A=60 and group B=120 min of clear fluid fasting. Data are median (IQR) or count (%)
. | Group A . | Group B . | P-value . |
---|---|---|---|
Hunger score (n=37/39) | 1 (0–2) | 1 (0–1) | 0.91 |
Thirst score† (n=37/39) | 1 (0–2) | 1 (0–1) | 0.25 |
Induction quality (n=65/66) | 1 (1–1) | 1 (1–1) | 0.11 |
Venous pH (n=59/61) | 7.35 (7.33–7.38) | 7.35 (7.33–7.38) | 0.41 |
Venous base excess (n=59/61) | −1.5 (−2.53–−0.83) | −1.75 (−2.9–−0.43) | 0.82 |
Venous blood glucose (n=59/61) | 5.2 (4.9–5.78) | 5.3 (4.9–5.78) | 0.82 |
Venous lactate (n=59/61) | 1.2 (0.9–1.58) | 1.0 (0.8–1.4) | 0.08 |
Nausea after operation (n=65/66) | 8 (12.5%) | 9 (13.84%) | 0.82 |
Vomiting after operation (n=65/66) | 3 (4.69%) | 4 (6.06%) | 0.73 |
PONV rescue (n=65/66) | 8 (12.3%) | 9 (13.63%) | 0.82 |
Recovery quality (n=65/66) | 1 (1–2) | 1 (1–2) | 0.74 |
. | Group A . | Group B . | P-value . |
---|---|---|---|
Hunger score (n=37/39) | 1 (0–2) | 1 (0–1) | 0.91 |
Thirst score† (n=37/39) | 1 (0–2) | 1 (0–1) | 0.25 |
Induction quality (n=65/66) | 1 (1–1) | 1 (1–1) | 0.11 |
Venous pH (n=59/61) | 7.35 (7.33–7.38) | 7.35 (7.33–7.38) | 0.41 |
Venous base excess (n=59/61) | −1.5 (−2.53–−0.83) | −1.75 (−2.9–−0.43) | 0.82 |
Venous blood glucose (n=59/61) | 5.2 (4.9–5.78) | 5.3 (4.9–5.78) | 0.82 |
Venous lactate (n=59/61) | 1.2 (0.9–1.58) | 1.0 (0.8–1.4) | 0.08 |
Nausea after operation (n=65/66) | 8 (12.5%) | 9 (13.84%) | 0.82 |
Vomiting after operation (n=65/66) | 3 (4.69%) | 4 (6.06%) | 0.73 |
PONV rescue (n=65/66) | 8 (12.3%) | 9 (13.63%) | 0.82 |
Recovery quality (n=65/66) | 1 (1–2) | 1 (1–2) | 0.74 |
Parental satisfaction as median (IQR). 0=not at all satisfied; 1=less satisfied; 2=satisfied; 3=very satisfied. Group A=60 and group B=120 min of clear fluid fasting. *P<0.05 was considered significant
Parental satisfaction concerning . | Group A (n=59) . | Group B (n=61) . | P-value . |
---|---|---|---|
Fasting time for clear fluid | 3 (3–3) | 3 (2–3) | 0.02* |
Fasting time for food/non-clear fluid | 3 (3–3) | 3 (2–3) | 0.28 |
Child behaviour at induction | 3 (3–3) | 3 (3–3) | 0.67 |
Postoperative recovery | 3 (3–3) | 3 (3–3) | 0.49 |
Overall perioperative performance | 3 (3–3) | 3 (3–3) | 0.62 |
Parental satisfaction concerning . | Group A (n=59) . | Group B (n=61) . | P-value . |
---|---|---|---|
Fasting time for clear fluid | 3 (3–3) | 3 (2–3) | 0.02* |
Fasting time for food/non-clear fluid | 3 (3–3) | 3 (2–3) | 0.28 |
Child behaviour at induction | 3 (3–3) | 3 (3–3) | 0.67 |
Postoperative recovery | 3 (3–3) | 3 (3–3) | 0.49 |
Overall perioperative performance | 3 (3–3) | 3 (3–3) | 0.62 |
Parental satisfaction as median (IQR). 0=not at all satisfied; 1=less satisfied; 2=satisfied; 3=very satisfied. Group A=60 and group B=120 min of clear fluid fasting. *P<0.05 was considered significant
Parental satisfaction concerning . | Group A (n=59) . | Group B (n=61) . | P-value . |
---|---|---|---|
Fasting time for clear fluid | 3 (3–3) | 3 (2–3) | 0.02* |
Fasting time for food/non-clear fluid | 3 (3–3) | 3 (2–3) | 0.28 |
Child behaviour at induction | 3 (3–3) | 3 (3–3) | 0.67 |
Postoperative recovery | 3 (3–3) | 3 (3–3) | 0.49 |
Overall perioperative performance | 3 (3–3) | 3 (3–3) | 0.62 |
Parental satisfaction concerning . | Group A (n=59) . | Group B (n=61) . | P-value . |
---|---|---|---|
Fasting time for clear fluid | 3 (3–3) | 3 (2–3) | 0.02* |
Fasting time for food/non-clear fluid | 3 (3–3) | 3 (2–3) | 0.28 |
Child behaviour at induction | 3 (3–3) | 3 (3–3) | 0.67 |
Postoperative recovery | 3 (3–3) | 3 (3–3) | 0.49 |
Overall perioperative performance | 3 (3–3) | 3 (3–3) | 0.62 |
No child experienced perioperative regurgitation or aspiration. Symptoms like dyspnoea, desaturation, or respiratory distress did not occur during recovery.
Discussion
This study compared gastric pH and residual gastric volumes after 1 vs 2 h of pre-anaesthetic clear fluid fasting in children undergoing general anaesthesia. Compared with previous studies investigating different fasting times, this study is the first to investigate a fluid fasting time as short as 1 h. As a main finding, no significant difference was observed for either gastric pH or residual gastric volume indexed to body weight after 1 vs 2 h of clear fluid fasting. While the 95% CI indicates that the gastric pH difference between the groups is smaller than the predefined value of 0.5, and thus certainly clinically irrelevant, the 95% CI of the GFVw difference may give rise to controversial discussion. Parents' satisfaction was greater when fluid fasting was shortened to 1 h.
While many clinical trials have been conducted to consolidate the existing ESA and ASA anaesthesia fasting guidelines2,3,8 (e.g. by comparing 2 h fluid fasting with more conservative concepts), shorter fasting times than currently recommended have, to our knowledge, not yet been investigated in a clinical setting. The Scandinavian recommendation explicitly deals with shorter clear fluid fastening times, allowing up to 150/75 ml of water in adults/children, respectively, given with premedication 1 h before anaesthesia start.9 So far only data from volunteer children undergoing magnetic resonance imaging have been used to demonstrate that gastric residual volumes decline to the range of overnight fasting baseline values within 1 h after drinking clear fluid.7
Median gastric residual volumes after 1 or 2 h clear fluid fasting in this study were within the range of previously observed values after 2 h fluid fasting, as summarized by Brady and colleagues.8 In comparison, gastric content volumes were slightly higher in children undergoing diagnostic magnetic resonance imaging,4 one reason for which may be that fasting times for non-clear fluids and food were shorter than in the actual data. Another possible reason is that gastric fluid sampling via oro-gastric tube may underestimate true gastric volume, despite gastric fluid being aspirated three times in different patient positions. Repetitive aspiration in supine or changing positions has been shown to enable a sampling of up to 96 or 97% of gastric fluid volume, respectively,10,11 whereas only 53 or 78% was recovered in other studies.12,13
Gastric pH values tended to be within the lower range of the studies reviewed by Brady and colleagues,8 which used different pH tests, such as pH paper, pH meter,14–16 Digital ionalyser pH meter,17–19 pH radiometer,20 or electrode,21 the latter also being used for the data presented here. The weak correlation between the amount of fluid drunk and gastric pH in group A suggests that fluid intake may indeed have a positive short-term effect on gastric pH. However, the correlation is very weak, non-existent after 2 h, and, with median gastric pH values similar in group A and B, it thus remains speculative as to whether drinking clear fluid has a dilutional effect on gastric pH.
In this study, a 1 h fluid fast did not reveal relevant advantages concerning hunger and thirst, induction quality, recovery, and parental satisfaction compared with 2 h of clear fluid fasting. This contrasts with other studies that showed significant disadvantages of a regimen prescribing ‘nil per os after midnight’ compared with shorter fluid abstinence of 150 and 180 min.22,23 As the interval between the two groups in this study differed by only 1 h, thirst may not have had as much impact on children's behaviour. Furthermore, in the two groups actual fasting times corresponded with those prescribed (i.e. they were as short as possible according to group allocation). In clinical practice, such optimal fasting times are difficult to realize and current international recommendations (ESA, ASA) are often considerably exceeded.4–6
Some limitations to this study have to be addressed. Aspiration of gastric fluid via oro-gastric tube may underestimate residual gastric volume as mentioned above. In some patients, the amount of gastric juice was not sufficient to measure gastric pH, thus the sample size required was slightly missed (reducing calculated power to 78%). As this study included only children classified ASA I or II without gastric disorders and undergoing elective surgery, the results cannot be directly transferred to other populations. Furthermore, the final amount and type of clear fluid intake was controlled but not strictly standardized. The outcome parameters gastric pH and residual gastric volume are only surrogate parameters for the risk of pulmonary aspiration, which is in itself not an adequate outcome measure because of its low incidence. This investigation covers a wide paediatric age range, like many similar published studies.8,24–26 Differences in gastric emptying half-life according to age have been observed in preterm vs term infants but have not been investigated for the age groups beyond.27
However, like previous investigations,4 this study clearly demonstrates once again that gastric residual volumes vary substantially in ‘normal’ physiology and an empty stomach cannot always be expected. This implies that a safe and smooth anaesthesia technique to prevent regurgitation by coughing, pressing, bucking movements, or hiccups is just as or even more important in minimizing the risk of pulmonary aspiration.
On the other hand, prolonged fasting in the absence of gastrointestinal impairment cannot further reduce gastric volumes or increase safety,4,8 but rather leads to unnecessary inconvenience for children and their care-givers and should therefore be avoided. Because, in current clinical practice, the recommended fasting times are often exceeded, a reduction to 1 h for clear fluids would allow the child to drink until hospital admission or even until a ‘stop drinking’ order of the anaesthetist in charge of the child is given (‘stop drinking on demand’).
Further studies are required to investigate shorter fluid fasting than currently recommended by the ASA or ESA, and future research should also analyse whether such a shortened fasting time can optimize preoperative care in daily practice. Alternative study designs including non-inferiority or equivalence studies may be useful to demonstrate that gastric pH and residual gastric volume stay within acceptable limits when the fluid fasting time is reduced.
Conclusion
When 1 vs 2 h of clear fluid fasting in healthy children are compared, neither gastric pH nor residual gastric volume show significant differences. Parental satisfaction may even be improved by a shortened fluid fasting time. The data presented do not provide evidence against fluid fasting shorter than currently recommended with respect to safety and comfort aspects, but data from a larger paediatric population are required.
Authors' contributions
A.R.S.: patient recruitment, clinical execution, data analysis, and interpretation, manuscript writing; P.B.: patient recruitment, clinical execution, and manuscript revision; L.S.: patient recruitment, clinical execution, and manuscript revision; T.S.: patient recruitment, clinical execution, and manuscript revision; B.B.: patient recruitment, clinical execution, and manuscript revision; T.R.: patient recruitment, clinical execution, and manuscript revision; C.S.: study protocol, clinical organization and assistance, and manuscript revision; R.K.: data analysis and interpretation, and manuscript revision; M.W.: study conception and manuscript revision; A.S.: study idea, study conception, study protocol, data analysis and interpretation, and manuscript writing.
Declaration of interest
None declared.
References
Author notes
Preliminary results of the study were presented at the 2012 SGAR meetings in Basel, and subsequently published as an abstract.
Comments
We would like to thank Prof. Maheshwari and colleagues for their comments on our study "Gastric pH and residual volume after 1 and 2 h fasting time for clear fluids in children" and would like to comment on their questions.
Before parental consent extended oral and written information was given to the patient and the parents, including the general risk of aspiration/regurgitation. It was pointed out that this risk might be increased due to shorter fasting times although prior MRI studies in healthy school children revealed that residual gastric volume one hour after clear fluid intake is close to baseline gastric volume after overnight fasting (1-3). None of the parents drew back their consent after randomisation to the 1 hour clear fluid fasting group.
In the past, a wide range of fluid amount and various types of fluid and food have been investigated with regard to residual gastric volume and gastric pH, as summarized in the Cochrane Review by Brady et al. (4). We chose 5ml clear fluid /kg bodyweight with a maximum intake of 150ml in order to have measureable impact on the improvement of subjective wellbeing, as represented by the secondary outcome parameters "feeling of thirst/hunger". Future projects certainly should include smaller amounts of fluid and also the impact of liberal, patient determined fluid intake.
In this study we did not compare the gastric pH between the oral and rectal premedication, as it was not the aim of the study. But to be able to show that your objection did not influence our results we compared oral (n=96) vs. rectal (n=22) premedication regarding gastric pH. Data are median and interquartile range, a p-value < 0.05 is significant. Statistical analysis found no significant difference between these to groups (oral: 1.42 [1.28 - 1.65] vs. rectal: 1.48 [1.36 - 1.66], p=0.236).
References
1) Schmitz A, Kellenberger CJ, Neuhaus D, et al. Fasting times and gastric contents volume in children undergoing deep propofol sedation--an assessment using magnetic resonance imaging. Paediatr Anaesth 2011; 21: 685-90
2) Schmitz A, Kellenberger CJ, Lochbuehler N, et al. Effect of different quantities of a sugared clear fluid on gastric emptying and residual volume in children: a crossover study using magnetic resonance imaging. Br J Anaesth 2012; 108: 644-7
3) Schmitz A, Kellenberger CJ, Liamlahi R, Studhalter M, Weiss M. Gastric emptying after overnight fasting and clear fluid intake: a prospective investigation using serial magnetic resonance imaging in healthy children. Br J Anaesth 2011; 107: 425-9
4) Brady M, Kinn S, NessV, O'Rourke K,Randhawa N, StuartP. Preoperative fasting for preventing perioperative complications in children. Cochrane Database Syst Rev 2009; CD005285
Conflict of Interest:
Alexander R. Schmidt is Corresponding Author of the article:"Gastric pH and residual volume after 1 and 2 h fasting time for clear fluids in children."
We read with interest the article "Gastric pH and residual volume after 1 and 2 h fasting time for clear fluids in children" by Schmidt and colleagues. While we commend the authors' for performing this interesting study and providing an incentive to revising fasting guidelines for clear fluids in children(1), we have few questions about their study.
Firstly, we are glad that no patient experienced perioperative regurgitation or aspiration. Regarding obtaining consent from parents of children especially in the group A with 60 min fasting for clear fluids, what was explained as a possible risk of regurgitation and aspiration and did it lead to any observed difference in parental approval for enrollment into study?
Secondly, the amount of clear fluid chosen to be administered in the study was 5 ml/kg, while earlier studies have used 2ml/kg as the preoperative fluid(2).
Lastly, was any pH difference observed in patients who received oral versus rectal midazolam as oral midazolam hydrochloride preparation with adjusted pH to 3(3) may be a confounding factor?
References:
1.Schmidt et al. Gastric pH and residual volume after 1 and 2 h fasting time for clear fluids in children. Br J Anaesth 114 (3): 477-82 (2015) doi:10.1093/bja/aeu399.
2.Crawford et al. Effects of duration of fasting on gastric fluid pH and volume in healthy children. Anesth Analg. 1990; 71(4):400-3.
3.Miller's Anesthesia, 7e. Ronald D. Miller. Elsevier Churchil Livingstone. Chapter 26 Intravenous Anesthetics.
Conflict of Interest:
None declared